Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer. Kearney M, Franks L, Lee S, Tiersten A, et al. Breast Cancer Res Treat 2021 Jun 24. pii: 10.1007/s10549-021-06306.

Read + Share

Amedeo Smart

Independent Medical Education

Kearney M, Franks L, Lee S, Tiersten A, et al. Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer. Breast Cancer Res Treat 2021 Jun 24. pii: 10.1007/s10549-021-06306.
PMID: 34169393